Recombinant cytomegalovirus vaccine

Details Recombinant cytomegalovirus vaccine Recombinant cytomegalovirus vaccine

1995-04-21

1997-01-07

Nucker, Christine M.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Recombinant virus encoding one or more heterologous proteins...

4242301, 4242331, 435 5, 435 693, 4351723, 4352351, 536 231, 536 2372, A61K 3912, A61K 39235, A61K 39245

Patent

active

055914390

ABSTRACT:
The present invention provides a non-defective adenovirus recombinant expression system for the expression of the HCMV gB subunit and for the expression of non-structural immediate-early exon 4 proteins, said recombinant HCMV-expressing adenovirus being useful as a vaccine.

REFERENCES:
patent: 3959466 (1976-05-01), Plotkin
patent: 4689225 (1987-08-01), Pereira
patent: 4920209 (1990-04-01), Davis et al.
patent: 5124440 (1992-06-01), Gehrz
J. Hanshaw, "Congenital Cytomegalovirus Infection: A Fifteen Year Perspective", J. Infec. Dis., 123(5):555-561 (May, 1971).
S. Plotkin et al, "Towne-Vaccine-Induced Prevention of Cytomegalovirus Disease after Renal Transplants", Lancet, 1:582-530 (Mar. 10, 1984) [Plotkin I].
S. Plotkin et al, "Clinical Trials of Immunization with the Towne 125 Strain of Human Cytomegalovirus", J. Infect. Dis., 134(5):470-475 (Nov., 1976) [Plotkin II].
S. Plotkin et al, "Prevention of Cytomegalovirus Disease by Towne Strain Live Attenuated Vaccine", in Birth Defects, Original Article Series, 20(1):271-287 (1984) [Plotkin III].
J. Glazer et al, "Live Cytomegalovirus Vaccination of Renal Transplant Candidates", Ann. Intern. Med., 91(5):676-683 (Nov., 1979).
Cranage et al., EMBO Journal, 5:3057-3063, 1986.
Alp et al., Journal of Virology, vol. 65, No. 9, 4812-4820, 1991.
M. Cranage et al, "identification of the Human Cytomegalovirus Glycoprotein B Gene and Induction of Neutralizing Antibodies via its Expression in Recombinant Vaccinia Virus", EMBO J., 5(11):3057-3063 (Nov., 1986).
D. Johnson et al, "Abundant Expression of Herpes Simplex Virus Glycoprotein gB Using an Adenovirus Vector", Virol., 164:1-14 (1988).
R. Dewar et al, "Synthesis and Processing of Human Immunodeficiency Virus Type 1 Envelope Proteins Encoded by a Recombinant Human Adenovirus", J. Virol., 63(1):129-136 (Jan., 1989).
A. Davis et al, "Expression of Hepatitis B Surface Antigen with a Recombinant Adenovirus", Proc. Natl. Acad. Sci. USA, 82:7560-7564 (Nov., 1985).
J. Morin et al, "Recombinant Adenovirus Induced Antibody Response to Heptitis B Virus Surface Antigen in Hamsters", Proc. Natl. Acad. Sci. USA, 84:4626-4630 (Jul., 1987).
R. Couch et al, "Immunization with Types 4 and 7 Adenovirus by Selective Infection of the Intestinal Tract", Am. Rev. Respir. Dis., 88;394-403 (1963).
E. Takafuji et al, "Simultaneous Administration of Live, Enteric-Coated Adenovirus Types 4, 7, and 21 Vaccines: Safety and Immunogenicity", J. Infect. Dis., 140(1):48-53 (Jul., 1979).
P. Collis et al, "Adenovirus Vaccines in Military Recruit Populations: A Cost-Benefit Analysis", J. Infect. Dis., 128(6):745-752 (Dec., 1973).
R. Stenberg et al, "Structural Analysis of the Major Immediate Early Gene of Human Cytomegalovirus", J. Virol., 49(1):190-199 (Jan., 1984).
N. Alp et al, "Fine Specificity of Cellular Immune Responses in Humans to Human Cytomegalovirus Immediate-Early 1 Protein", J. Virol., 65(9):4812-4820 (Sep., 1991).
GenBank data entry, Access #M11630, Code #HS5MIE4, (Sep. 15, 1989).
R. Lerner et al, "The Development of Synthetic Vaccines", in The Biology of Immunologic Disease, Chapter 31, pp. 331-338 (Spring, 1983).
H. Volkmer et al, "Cytolytic T Lymphocyte Recognition of the Murine Cytomegalovirus Nonstructural Immediate-Early Protein PP89 Expressed by Recombinant Vaccinia Virus", J. Exp. Med., 166(3):668-677, Abstract (Sep., 1987).

Affiliated with

Also associated with

Rating

Recombinant cytomegalovirus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant cytomegalovirus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant cytomegalovirus vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1762302